Nasomixin C.M. (Phenylephrine Hydrochloride)

Phenylephrine Hydrochloride is a topical alpha‑adrenergic decongestant that reduces nasal mucosal swelling.

• Nasal congestion due to common cold: reduces swelling of nasal mucosa, improving airflow.
• Sinusitis-related congestion: alleviates blockage in sinus passages, facilitating drainage.
• Allergic rhinitis: diminishes nasal edema caused by allergic inflammation, easing breathing.
• Post‑nasal drip associated congestion: lessens mucosal swelling, helping to clear secretions.

• Phenylephrine Hydrochloride acts as an alpha‑adrenergic receptor agonist on the vascular smooth muscle of the nasal mucosa. By stimulating α1‑adrenergic receptors, it induces vasoconstriction of the submucosal blood vessels, leading to reduced blood flow, decreased edema, and consequently improved nasal patency. The localized effect limits systemic absorption, allowing rapid onset of decongestion within minutes after intranasal administration.

Phenylephrine nasal administration may be associated with a range of adverse reactions, varying from mild to serious.

Common Side Effects

• Nasal irritation or burning sensation
• Dryness of nasal mucosa
• Headache
• Rebound nasal congestion with prolonged use

Serious or Rare Side Effects

• Hypertension or marked increase in blood pressure
• Cardiac arrhythmias or tachycardia
• Severe allergic reaction (anaphylaxis)
• Nasal septum perforation (rare with misuse)

When using Phenylephrine Hydrochloride nasal products, certain precautions should be observed to ensure safe and effective use.

• Contraindicated in patients with severe hypertension: avoid use or seek medical advice.
• Use with caution in individuals taking monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis.
• Limit duration of use to no more than three consecutive days: prolonged use may cause rebound congestion.
• Pregnant or breastfeeding women should consult a healthcare professional before use.
• Children under a specified age should only use formulations approved for pediatric use.
• Store at room temperature below 25°C: keep in the original container, protect from moisture and direct sunlight.

Phenylephrine Hydrochloride can interact with other medicines, influencing its safety profile.

Major Interactions (Avoid)

• MAO inhibitors (e.g., phenelzine, tranylcypromine): may cause severe hypertension.
• Other sympathomimetic agents (e.g., pseudoephedrine, ephedrine): additive vasoconstrictive effect.
• Certain antidepressants (e.g., tricyclics) that increase catecholamine levels: risk of hypertensive episodes.

Moderate Interactions (Monitor Closely)

• Antihypertensive drugs (e.g., beta‑blockers, ACE inhibitors): phenylephrine may reduce their efficacy.
• Diuretics: may potentiate blood pressure changes.
• Selective serotonin reuptake inhibitors (SSRIs): possible modest increase in blood pressure.